A hierarchical qpcr-dpcr diagnostic framework for high-resolution toxinotyping and absolute quantification of clostridioides difficile and clostridium perfringens
Active Cooperative Agreement Awarded
- Award ID
- U18FD008901
- Recipient
-
Auburn University UEI DMQNDJDHTDG4
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $81,531
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 18% complete
- Funding agency
- Food and Drug Administration Department of Health and Human Services
- Place of performance
- Auburn University, AL 36849, USA
Award details come from USAspending.gov.
Description
- Abstract
- This research proposal establishes a robust, three-tier molecular framework designed to enhance the surveillance of toxigenic clostridioides difficile and clostridium perfringens within the animal feed and livestock supply chain. Clostridial pathogens, characterized by their ability to form environmentally resilient spores, pose a dual threat to veterinary health and human food safety. Traditional detection methods often struggle with high levels of PCR inhibitors found in complex agricultural matrices, such as meat-and-bone meal and diarrheic fecal matter. The proposed hierarchical framework utilizes a tiered diagnostic approach: ● tier 1: a multiplex qpcr screening assay for rapid, high-throughput identification of major C. Difficile toxinotypes (tcda, tcdb, cdta, cdtb). ● tier 2: a multiplex qpcr screening assay for rapid, high-throughput identification of major C. Perfringens toxinotypes (alpha, beta, epsilon, and iota). ● tier 3: a droplet digital PCR (DPCR) system for absolute quantification and differentiation of major toxinotypes for C. Difficile and perfringens. ● tier 4: comprehensive method validation utilizing both controlled spiking two multiplex pcrs and the DPCR. ● tier 5: application of the validated two multiplex pcrs and the DPCR on clinical field samples and raw food diets. Central to this framework is a streamlined DNA extraction process optimized for both vegetative cells and dormant spores. Preliminary investigations revealed that high-velocity mechanical homogenization (zirconia bead-beating) provides a universal lysis solution. Notably, our data indicates that lysozyme treatment offers no statistically significant benefit to DNA recovery or downstream PCR sensitivity, allowing for a more cost-effective and rapid response tool for the FDA VET-lirn network. The validation evaluates the framework's performance using simultaneous CO-spiking studies in finished swine and poultry feeds. Furthermore, the assay's clinical utility will be benchmarked against fecal samples from diarrheic animals with known clostridial culture results. By comparing molecular toxinotyping directly with traditional culture-based phenotypes, this work enables regulatory authorities to differentiate between background environmental presence and high-risk toxigenic outbreaks. This hierarchical approach ensures the integrity of the farm-to- fork continuum by providing a clear path from rapid screening to absolute, validated quantification.
Quick answers
Who received award U18FD008901?
U18FD008901 was awarded to Auburn University by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.
How much is award U18FD008901 worth?
$81,531 has been obligated on U18FD008901.
Which agency awarded U18FD008901?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008901, with funding from Food and Drug Administration (Department of Health and Human Services).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award